tirzepatide slows gastric emptying A 32-year-old man developed gastroparesis after taking for weight loss, which isn't approved in India. Doctors advise against using it without medical supervision Liraglutide, semaglutide, and tirzepatide delay

Even for those without insurance, a suite of options is discussed to underline our ethos that financial barriers should never impede effective weight loss treatment

In any case, the administration of the drug should only be done after consultation with the treating physician, who will assess the potential risks and benefits of its use.

Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism

Australia's Chief Medical Officer and the medicines regulator, the Therapeutic Goods Administration, have warned Australians not to take unapproved peptides, saying they were often poorly labelled and presented a health risk